Literature DB >> 32436441

Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.

Jerome R Lechien1,2, Maria Rosaria Barillari3, Lionel Jouffe1,4, Sven Saussez2,5.   

Abstract

Based on observations described in our letter, we can draw the following conclusions: (1) anosmia must imperatively be added to the list of specific symptoms of COVID-19 infection, (2) anosmia can serve as a free and specific diagnostic tool for developing countries currently affected by the pandemic, (3) the mechanisms of COVID-19 anosmia seem not to directly involve nasal obstruction but rather seem to be related to damage the olfactory neuroepithelium.

Entities:  

Keywords:  COVID-19; anosmia; diagnostic; neuroepithelium

Mesh：

Year:  2020        PMID： 32436441     DOI： 10.1177/0145561320925191

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN： 0145-5613            Impact factor:   1.697


  7 in total

1.  COVID-19-associated meningoencephalitis: A care report and literature review.

Authors:  Pu Lv; Fen Peng; Yeqiong Zhang; Linwei Zhang; Na Li; Lili Sun; Yu Wang; Pihua Hou; Tiequn Huang; Xiaoping Wang
Journal:  Exp Ther Med       Date:  2021-02-14       Impact factor: 2.447

2.  Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI.

Authors:  M F V V Aragão; M C Leal; O Q Cartaxo Filho; T M Fonseca; M M Valença
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

3.  Frequency and Severity of Ear-Nose-Throat (ENT) Symptoms during COVID-19 Infection.

Authors:  Natalia Zięba; Grażyna Lisowska; Adam Dadok; Joanna Kaczmarek; Grażyna Stryjewska-Makuch; Maciej Misiołek
Journal:  Medicina (Kaunas)       Date:  2022-04-29       Impact factor: 2.948

4.  Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences.

Authors:  Christopher S von Bartheld; Molly M Hagen; Rafal Butowt
Journal:  ACS Chem Neurosci       Date:  2020-09-17       Impact factor: 4.418

5.  Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Stéphane Hans; Sven Saussez; Luigi A Vaira; Giacomo De Riu; Giovanni Cammaroto; Younes Chekkoury-Idrissi; Marta Circiu; Lea Distinguin; Fabrice Journe; Christophe de Terwangne; Shahram Machayekhi; Maria R Barillari; Christian Calvo-Henriquez
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-16       Impact factor: 2.503

6.  Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population.

Authors:  Giovanni Maconi; Cristina Bosetti; Alberta De Monti; Ray Kiran Boyapati; Edward Shelton; Nicole Piazza; Anna Maria Carvalhas Gabrielli; Marco Vincenzo Lenti; Cristina Bezzio; Chiara Ricci; Salvatore Greco; Samanta Romeo; Francesco Giangregorio; Daniele Gridavilla; Fabio Tagliani; Alessandro Massari; Luca Pastorelli; Antonio Di Sabatino; Simone Saibeni; Saverio Alicante; Francesca Ferretti; Giuliano Rizzardini; Massimo Galli; Sandro Ardizzone
Journal:  Dig Liver Dis       Date:  2020-12-26       Impact factor: 4.088

7.  COVID-19's natural course among ambulatory monitored outpatients.

Authors:  Barbora Weinbergerova; Jiri Mayer; Stepan Hrabovsky; Zuzana Novakova; Zdenek Pospisil; Lucie Martykanova; Katerina Hortova; Lucie Mandelova; Karel Hejduk; Renata Chloupková; Michal Pospisil; Martina Doubkova; Vladimir Marek; Renata Novotna; Martin Dolecek; Hana Matejovska Kubesova; Kristian Brat; Radana Parizkova; Petr Husa; Marek Mechl; Zdenek Kral; Martina Lengerova
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.